Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-107P is a nonfunctional pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is a highly conserved, noncoding component of the spliceosome, essential for mRNA splicing in the nucleus of eukaryotes[5][3]. U6 pseudogenes such as RNU6-107P are present in multiple copies in the genome and do not encode functional RNA, nor are they known to be transcribed or have a direct role in cellular processes[5][1]. The presence of such pseudogenes may reflect evolutionary processes and genomic architecture, but RNU6-107P itself is not implicated in disease mechanisms, therapeutic intervention, or drug interaction. Summary of evidence and context: - U6 snRNA is essential for splicing, but RNU6-107P is a pseudogene—a genomic sequence resembling a gene but nonfunctional[5]. - The U6 gene family includes many functional genes and many pseudogenes, commonly found as genomic "back-ups" or relics, but these pseudogenes do not produce proteins or functional RNA[5][1]. - No evidence exists for RNU6-107P as a biomarker, therapeutic target, or a protein-interacting entity. It is not a receptor, enzyme, transporter, or drug target[5][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 107, pseudogene (RNU6-107P).